-
2 weeks ago | 
healthday.com | Lori Solomon |Farrokh Sohrabi
Published on: Jun 13, 2025, 2:59 pmUpdated on: Jun 13, 2025, 2:59 pmLoading content, please wait...
-
2 weeks ago | 
healthday.com | Lori Solomon
Published on: Jun 12, 2025, 3:52 pmUpdated on: Jun 12, 2025, 3:52 pmLoading content, please wait...
-
2 weeks ago | 
medicalxpress.com | Lori Solomon |Sadie Harley |Andrew Zinin
The U.S. Food and Drug Administration has approved George Medicines' Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. The pill is available in a standard dose, as well as two low doses, and can be used in those initiating treatment.
-
2 weeks ago | 
medicalxpress.com | Lori Solomon |Gaby Clark |Andrew Zinin
Medical school attrition rates are high among lesbian, gay, or bisexual (LGB) medical students, according to a research letter published online June 10 in JAMA Network Open. Mytien Nguyen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues examined attrition rates at the intersection of sexual orientation, race, ethnicity, and sex among a national cohort of medical students.
-
2 weeks ago | 
healthday.com | Lori Solomon
Sonu BandPhoto: SoundHealthPublished on: Jun 10, 2025, 7:40 pmUpdated on: Jun 10, 2025, 7:40 pmLoading content, please wait...
-
2 weeks ago | 
medicalxpress.com | Lori Solomon |Robert Egan
The U.S. Food and Drug Administration has approved the Sonu Band, an artificial intelligence-enabled, wearable medical device for at-home treatment of moderate-to-severe nasal congestion in pediatric patients aged 12 and up. This expanded approval makes Sonu the first FDA-approved, drug-free solution for nasal congestion due to allergic and nonallergic rhinitis in children ages ≥12 years.
-
3 weeks ago | 
medicalxpress.com | Lori Solomon |Stephanie Baum |Andrew Zinin
Parental education may protect offspring's cognitive health later in life, according to a study published online May 30 in JAMA Network Open. Shengyu Luo, from Sun Yat-Sen University in Guangzhou, China, and colleagues evaluated the association of maternal and paternal education with cognitive decline over time among middle-aged and older adults in four countries. The analysis included 7,898 participants from China, 12,402 from the United States, 6,603 from England, and 9,162 from Mexico.
-
3 weeks ago | 
medicalxpress.com | Lori Solomon |Sadie Harley |Andrew Zinin
Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online in JAMA Oncology. Kevin T. Liou, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a randomized trial to evaluate acupuncture (10 weekly standardized treatments) relative to usual care for nocturia in prostate cancer survivors.
-
3 weeks ago | 
medicalxpress.com | Lori Solomon |Andrew Zinin
Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according to a study published online May 13 in JEADV Clinical Practice. Michael J. Diaz, from the College of Medicine at the University of Florida in Gainesville, and colleagues quantified the extent to which psoriasis severity correlates with the risk for developing specific sleep disorders.
-
1 month ago | 
medicalxpress.com | Lori Solomon |Andrew Zinin
Male athletes with high-volume exercise training have a higher burden of calcified plaque than male nonathletes, according to a review published in the June issue of JACC: Advances. Ahmed Abdelaziz, M.D., from the Medical Research Group of Egypt at the Negida Academy in Arlington, Massachusetts, and colleagues evaluated the impact of endurance exercise on coronary atherosclerosis assessed by cardiac computed tomography in athletes and nonathletes.
